363 related articles for article (PubMed ID: 34669197)
21. [Gestational trophoblastic disease].
Allias F; Bolze PA; Gaillot-Durand L; Devouassoux-Shisheboran M;
Ann Pathol; 2014 Dec; 34(6):434-47. PubMed ID: 25499859
[TBL] [Abstract][Full Text] [Related]
22. The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study.
Yamamoto E; Trinh TD; Sekiya Y; Tamakoshi K; Nguyen XP; Nishino K; Niimi K; Kotani T; Kajiyama H; Shibata K; Le QT; Kikkawa F
Nagoya J Med Sci; 2020 May; 82(2):183-191. PubMed ID: 32581399
[TBL] [Abstract][Full Text] [Related]
23. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
Braga A; Maestá I; Short D; Savage P; Harvey R; Seckl MJ
BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
[TBL] [Abstract][Full Text] [Related]
24. State-of-the-Art Workup and Initial Management of Newly Diagnosed Molar Pregnancy and Postmolar Gestational Trophoblastic Neoplasia.
Elias KM; Berkowitz RS; Horowitz NS
J Natl Compr Canc Netw; 2019 Nov; 17(11):1396-1401. PubMed ID: 31693988
[TBL] [Abstract][Full Text] [Related]
25. Epidemiologic study on gestational trophoblastic diseases in Japan.
Yamamoto E; Nishino K; Niimi K; Ino K
J Gynecol Oncol; 2022 Nov; 33(6):e72. PubMed ID: 36047375
[TBL] [Abstract][Full Text] [Related]
26. Gestational trophoblastic neoplasia with extrauterine metastasis but lacked uterine primary lesions: a single center experience and literature review.
Li J; Wang Y; Lu B; Lu W; Xie X; Shen Y
BMC Cancer; 2022 May; 22(1):509. PubMed ID: 35524210
[TBL] [Abstract][Full Text] [Related]
27. Surveillance for gestational trophoblastic neoplasia following molar pregnancy: a cost-effectiveness analysis.
Albright BB; Myers ER; Moss HA; Ko EM; Sonalkar S; Havrilesky LJ
Am J Obstet Gynecol; 2021 Nov; 225(5):513.e1-513.e19. PubMed ID: 34058170
[TBL] [Abstract][Full Text] [Related]
28. Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study.
Braga A; Paiva G; Ghorani E; Freitas F; Velarde LGC; Kaur B; Unsworth N; Lozano-Kuehne J; Dos Santos Esteves APV; Rezende Filho J; Amim J; Aguiar X; Sarwar N; Elias KM; Horowitz NS; Berkowitz RS; Seckl MJ
Lancet Oncol; 2021 Aug; 22(8):1188-1198. PubMed ID: 34181884
[TBL] [Abstract][Full Text] [Related]
29. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
Dantas PR; Maestá I; Cortés-Charry R; Growdon WB; Braga A; Rudge MV; Berkowitz RS
J Reprod Med; 2012; 57(7-8):305-9. PubMed ID: 22838246
[TBL] [Abstract][Full Text] [Related]
30. Gestational trophoblastic disease- rare, sometimes dramatic, and what we know so far.
Strickland AL; Gwin K
Semin Diagn Pathol; 2022 May; 39(3):228-237. PubMed ID: 35400536
[TBL] [Abstract][Full Text] [Related]
31. Management of gestational trophoblastic disease in developing countries.
Sivanesaratnam V
Best Pract Res Clin Obstet Gynaecol; 2003 Dec; 17(6):925-42. PubMed ID: 14614890
[TBL] [Abstract][Full Text] [Related]
32. Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?
Earp KE; Hancock BW; Short D; Harvey RA; Fisher RA; Drew D; Sarwar N; Tidy JA; Winter MC; Chien P; Seckl MJ
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():117-119. PubMed ID: 30684876
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and Management of Gestational Trophoblastic Disease: A Comparative Review of National and International Guidelines.
Tsakiridis I; Giouleka S; Kalogiannidis I; Mamopoulos A; Athanasiadis A; Dagklis T
Obstet Gynecol Surv; 2020 Dec; 75(12):747-756. PubMed ID: 33369685
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy is not needed when complete evacuation of gestational choriocarcinoma leads to hCG normalization.
Bolze P; Schoenen S; Margaillan M; Braga A; Sauthier P; Elias K; Seckl M; Winter M; Coulter J; Lok C; Joneborg U; Undurraga Malinverno M; Hajri T; Massardier J; You B; Golfier F; Goffin F
Eur J Surg Oncol; 2024 Mar; 50(3):108012. PubMed ID: 38350264
[TBL] [Abstract][Full Text] [Related]
35. Gestational trophoblastic neoplasia: Novelties and challenges.
Silva ALMD; Monteiro KDN; Sun SY; Borbely AU
Placenta; 2021 Dec; 116():38-42. PubMed ID: 33685753
[TBL] [Abstract][Full Text] [Related]
36. Surgical Management of Gestational Trophoblastic Disease.
Coopmans L; Larsson A; Joneborg U; Lok C; van Trommel N
Gynecol Obstet Invest; 2024; 89(3):214-229. PubMed ID: 37788661
[TBL] [Abstract][Full Text] [Related]
37. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
Elmer DB; Granai CO; Ball HG; Curry SL
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
[TBL] [Abstract][Full Text] [Related]
38. Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation?
Braga A; Torres B; Burlá M; Maestá I; Sun SY; Lin L; Madi JM; Uberti E; Viggiano M; Elias KM; Berkowitz RS
Gynecol Oncol; 2016 Dec; 143(3):558-564. PubMed ID: 27640962
[TBL] [Abstract][Full Text] [Related]
39. Worldwide survey of the results of treating gestational trophoblastic disease.
Kohorn EI
J Reprod Med; 2014; 59(3-4):145-53. PubMed ID: 24724223
[TBL] [Abstract][Full Text] [Related]
40. [Clinical and radiological features of gestational trophoblastic tumors].
Mamouni N; Boumhaoued S; Erraghay S; Boubou M; Bouchikhi C; Banani A
Pan Afr Med J; 2017; 28():228. PubMed ID: 29629014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
